A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period
Clinical trial NCT05175105 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05175105
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-06
- Primary completion
- 2024-12-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.